- Home
- ACIW vs PCVX Comparison
ACIW vs PCVX Comparison
Compare ACIW & PCVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIW
- PCVX
- Stock Information
- Founded
- ACIW 1975
- PCVX 2013
- Country
- ACIW United States
- PCVX United States
- Employees
- ACIW N/A
- PCVX N/A
- Industry
- ACIW EDP Services
- PCVX Biotechnology: Pharmaceutical Preparations
- Sector
- ACIW Technology
- PCVX Health Care
- Exchange
- ACIW Nasdaq
- PCVX Nasdaq
- Market Cap
- ACIW 4.7B
- PCVX 4.0B
- IPO Year
- ACIW 1995
- PCVX 2020
- Fundamental
- Price
- ACIW $53.02
- PCVX $41.62
- Analyst Decision
- ACIW Strong Buy
- PCVX Strong Buy
- Analyst Count
- ACIW 3
- PCVX 8
- Target Price
- ACIW $60.00
- PCVX $114.17
- AVG Volume (30 Days)
- ACIW 888.8K
- PCVX 2.0M
- Earning Date
- ACIW 11-06-2025
- PCVX 11-04-2025
- Dividend Yield
- ACIW N/A
- PCVX N/A
- EPS Growth
- ACIW 38.68
- PCVX N/A
- EPS
- ACIW 2.37
- PCVX N/A
- Revenue
- ACIW $1,700,613,000.00
- PCVX N/A
- Revenue This Year
- ACIW $10.58
- PCVX N/A
- Revenue Next Year
- ACIW $6.98
- PCVX N/A
- P/E Ratio
- ACIW $22.28
- PCVX N/A
- Revenue Growth
- ACIW 11.22
- PCVX N/A
- 52 Week Low
- ACIW $40.45
- PCVX $27.66
- 52 Week High
- ACIW $59.71
- PCVX $118.62
- Technical
- Relative Strength Index (RSI)
- ACIW 63.47
- PCVX 72.10
- Support Level
- ACIW $51.41
- PCVX $31.89
- Resistance Level
- ACIW $54.28
- PCVX $43.76
- Average True Range (ATR)
- ACIW 1.16
- PCVX 1.88
- MACD
- ACIW -0.01
- PCVX 1.04
- Stochastic Oscillator
- ACIW 70.39
- PCVX 82.12
About ACIW ACI Worldwide Inc.
ACI Worldwide Inc develops, markets and installs a portfolio of software products focused on facilitating electronic payments. The firm also leverages its distribution network in the Americas; Europe, the Middle East, and Africa, or EMEA; and Asia-Pacific regions to sell software developed by third parties. ACI software products process payment transactions for retail banking clients, billers such as utilities and healthcare providers, and community banks and credit unions. ACI's customers are financial institutions all over the world, but majority of the revenue is generated in the United States and EMEA regions.
About PCVX Vaxcyte Inc.
Vaxcyte Inc is a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. It is developing broad-spectrum conjugate and novel protein vaccines to prevent or treat bacterial infectious diseases. Its product comprises of Pneumococcal conjugate vaccine. The firm's product candidate consists of VAX-31, VAX-24, VAX-A1, VAX-PG, VAX-GI, and Others.